Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry

Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK
Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )
8 Sep 2015

Primary results from the MABLE phase IIIb study

Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France
Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )
8 Sep 2015

Results of subgroup analysis of the HELIOS trial

Dr Paula Cramer – University of Cologne, Cologne, Germany
Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
8 Sep 2015

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors

Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015

Will chemotherapy remain the cornerstone of CLL management?

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany
Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
8 Sep 2015

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA
Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )
7 Sep 2015

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA
History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )
7 Sep 2015

Translational research and the future of CLL treatment

Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA
Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )
7 Sep 2015

Mapping the relationship between genetics and the impact of aspirin on colorectal cancer

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA
Mapping the relationship between genetics and the impact of aspirin on colorectal cancer ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )
3 Sep 2015

Why doesn’t aspirin protect everyone from colorectal cancer?

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA
Why doesn’t aspirin protect everyone from colorectal cancer? ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )
2 Sep 2015

Conference overview: Aspirin in the 21st Century

Prof Peter Rothwell – The University of Oxford, Oxford, UK
Conference overview: Aspirin in the 21st Century ( Prof Peter Rothwell – The University of Oxford, Oxford, UK )
2 Sep 2015

Aspirin for cancer treatment and prevention

Prof Peter Elwood – Cardiff University, Cardiff, UK
Aspirin for cancer treatment and prevention ( Prof Peter Elwood – Cardiff University, Cardiff, UK )
2 Sep 2015